Medical Pharmacology Chapter 35  Antibacterial Drugs

Section Table of Contents

Site Table of Contents

Previous Page

Next Page

  • Second Generation CephalosporinsCefoxitin
    Cefoxitin: Audio Overview

     

  •  

    • Structural class and overview

      • Cefoxitin is a parenteral cephamycin typically grouped with second-generation cephalosporins.2,3 

        • Cefoxitin is derived from cephamycin C and is characterized by a 7-α-methoxy group on the β-lactam ring, which confers enhanced stability against many plasmid-encoded β-lactamases and explains much of its anaerobic and Gram-negative activity.

         

        • Microbiological Characterization

          • Cefoxitin exhibits broad gram-negative in anaerobic activity, its β-lactamase stability.

            • These characteristics allow cefoxitin to be viewed as a bridge between cephalosporins and later broad-spectrum β-lactams.4

          • Additional studies Describe cefoxitin exhibiting strong activity versus many cephalothin-resistant Enterobacterales and good coverage of Bacteroides fragilis.5

        • Mechanism of Action

          • Cefoxitin is a β-lactam that inhibits cell-wall synthesis by binding to penicillin-binding proteins (PBPs) (transpeptidases).

            • This activity the final cross-linking steps of peptidoglycan, leading to structurally fragile cell walls and ultimately bacterial lysis.6,7

              • Points of emphasis include:

                • Bactericidal PBP-binding mechanism

                • Relative stability to many penicillinases and cephalosporinases.

                • Potent activity against anaerobes in the spectrum of Gram-negative rods.

        • Spectrum of activity

          • Major considerations

            • Gram-positive aerobes (MSSA, streptococci)6,7 

              • Active against methicillin-susceptible Staphylococcus aureus and various streptococci (S. pyogenes, S. pneumoniae, S. agalactiae)

              • MRSA and enterococci are intrinsically resistant.

            • Gram-negative anaerobes

              • Cefoxitin exhibits good activity activity against many E. coli, Klebsiella spp., Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia spp., Haemophilus influenzae, and Neisseria gonorrhoeae.

              • Poor activity with cefoxitin has been noted for: Pseudomonas aeruginosa and many Enterobacter, Serratia, Citrobacter (especially AmpC-producers).

              • E. coli

                 

              • Klebsiella pneumoniae
                • Klebsiella pneumoniae

                • "Klebsiella is a genus of Gram-negative, oxidase-negative, rod -shaped bacteria where they prominent polysaccharide-based capsule."

                  • Ryan KJ; Ray CG, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. p. 370.

                  • Example of Klebsiella species include Klebsiella aerogenes, Klebsiella pneumoniae, and Klebsiella variicola

                • Attribution

              •  

                Haemophilus influenzae

                 

              • Chest radiograph and influenza and H. Influenza, posterioanterior, annotated JPEG

             

            • Anaerobes

              • Cefoxitin exhibits excellent activity vs Bacteroides spp., including B. fragilis, Clostridium spp., Peptostreptococcus, and related anaerobes.

                • Accordingly, this antibiotic is  especially attractive for intra-abdominal and pelvic infections.6,8 
                   

Section Table of Contents

Site Table of Contents

 

 

References
  1. MacDougall C Chapter 58 Cell Envelope Disruptors: In Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton LL Knollman BC eds) McGraw Hill LLC (2023).

  2. Cefoxitin. https://en.wikipedia.org/wiki/Cefoxitin

  3. Global health: antimicrobial-resistance. https://pdb101.rcsb.org/global-health/antimicrobial-resistance/drugs/antibiotics/cell-wall-biosynthesis/penicillin-binding-protein/beta-lactams/cefoxitin/cefoxitin

  4. Neu HC. “Cefoxitin, a semisynthetic cephamycin antibiotic.” Antimicrobial Agents and Chemotherapy. 1974;6(2):159-168.  Antimicrob Agents Chemother. 1974 August;6(2): 170-176. https://pmc.ncbi.nlm.nih.gov/articles/PMC444623

  5. Stapley EO, Miller AK, Hernandez S, et al. “Cefoxitin and the cephamycins: microbiological studies.” Journal of Antimicrobial Chemotherapy. 1979;5(Suppl A):33-45. https://pmc.ncbi.nlm.nih.gov/articles/PMC444623

  6. Cefoxitin: Package Insert / Prescribing Info. Drugs.com. https://www.drugs.com/pro/cefoxitin.htm

  7. Mefoxin (cefoxitin for injection). FDA labeling. Revised February, 2017. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050517s053lbl.pdf

  8. Brook I Wexler H Goldstein EJC Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing. Clinical Microbiology Reviews: July 2013. Volume 26. Issue 3. https://journals.asm.org/doi/epub/10.1128/cmr.00086-12

 

This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.